相关实验视频
Updated: Jan 11, 2026

08:53
A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
Published on: September 15, 2021
3.2K
首次编辑用于调查与致病性PRPH2变体相关的异常拼接缺陷
Bruna Lopes da Costa1,2,3, Kyle M Helms4,5, Keith Theodore3
1Jonas Children's Vision Care (JCVC) and Barbara & Donald Jonas Stem Cell Laboratory, New York-Presbyterian Hospital, New York, NY 10032, USA.
Molecular therapy. Nucleic acids
|November 10, 2025
概括
总编辑精确地纠正了患者衍生的干细胞中的致病性PRPH2基因变异,恢复了正常的基因功能,并为遗传性视网膜疾病提供了潜在的治疗方法.
科学领域:
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
- 眼科医生 眼科 眼科
背景情况:
- PRPH2基因对光受体功能至关重要,其突变导致遗传性视网膜疾病 (IRD).
- 在PRPH2中,一种特定的拼接部位变异c.828+1G>A与IRD有关.
- 人类诱导多能干细胞 (hiPSCs) 为研究IRD和开发疗法提供了一个模型.
研究的目的:
- 为了研究c.828+1G>APRPH2变种的致病作用.
- 利用主要编辑 (PE) 技术在hiPSC中进行精确的基因编辑.
- 为基因型-表型研究和PRPH2介导IRDs的治疗开发奠定基础.
主要方法:
- 开发了一个全合一的主要编辑结构,与GFP记者一起进行编辑效率.
- 在hiPSC中安装并纠正c.828+1G>A PRPH2变体.
- 分析了编辑的hiPSCs和衍生的视网膜器官,以寻找非目标突变,型稳定性和转录变化.
主要成果:
- 成功生成了异和同的hiPSC克隆,没有可检测的异突变或型异常.
- 证实c.828+1G>APRPH2突变激活了一个神秘的拼接部位,导致内子保留和突变转录.
- 证明PE校正恢复了正规的PRPH2转录,并减少了编辑的hiPSC中的突变转录.
结论:
- 主编辑是一种准确和安全的方法,用于安装和纠正hiPSCs中的致病性PRPH2突变.
- 这种方法可以创建准确的疾病模型来研究PRPH2介导的IRD.
- 这些发现支持PE作为PRPH2相关的遗传视网膜疾病的有前途的治疗策略.
相关概念视频
Alternative RNA Splicing
24.6K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
24.6K
Alternative RNA Splicing
4.8K
4.8K
RNA Splicing
60.3K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.3K
Pre-mRNA Processing: RNA Splicing
6.5K
6.5K
Pre-mRNA Processing: Modification of pre-mRNA Ends
13.5K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
13.5K
RNA Editing
9.7K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.7K

